Neuronetics (STIM) Net Shares Issued and Repurchased (2017 - 2026)
Neuronetics' (STIM) quarterly Net Shares Issued and Repurchased came in at $403000.0 in Q1 2026, up 50.37% year-over-year from $268000.0 in Q1 2025, and down 67.76% quarter-over-quarter from $1.2 million in Q4 2025.
Powered by 
Analysis
Neuronetics (STIM) Net Shares Issued and Repurchased (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $403000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased rose 50.37% year-over-year to $403000.0 in Q1 2026; TTM through Mar 2026 was $403000.0, a 50.37% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 211.72% from the prior year.
- Net Shares Issued and Repurchased was $403000.0 for Q1 2026 at Neuronetics, down from $1.2 million in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $1.2 million in Q4 2025 and troughed at $20000.0 in Q1 2022.
- A 5-year average of $387555.6 and a median of $392000.0 in 2023 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased sank 86.75% in 2022 and jumped 730.0% in 2023, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $420000.0 in 2022, then retreated by 6.67% to $392000.0 in 2023, then gained by 2.3% to $401000.0 in 2024, then jumped by 211.72% to $1.2 million in 2025, then sank by 67.76% to $403000.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $403000.0 (Q1 2026), $1.2 million (Q4 2025), and $268000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.22 Bn | 178.62 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.47 Bn | 119.26 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.41 Bn | 109.59 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.06 Bn | 101.58 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.48 Bn | 65.94 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.33 Bn | 30.38 Bn | 830.00 Mn | - |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | - |
| 10 | Neuronetics | 224.87 Mn | 205.44 Mn | 21.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 403,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Mar 31, 2025 | 268,000.00 |
| Dec 31, 2024 | 401,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | 392,000.00 |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 359,000.00 |
| Mar 31, 2021 | 151,000.00 |
| Dec 31, 2020 | 1.03 Mn |
| Mar 31, 2020 | 70,000.00 |
| Dec 31, 2019 | 856,000.00 |
| Mar 31, 2019 | 476,000.00 |
| Dec 31, 2018 | 584,000.00 |
| Dec 31, 2017 | 967,000.00 |